Center-Authored Papers

Filters: Author is Buchegger, Franz  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Wilbur SD, Park SI, Chyan M-K, Wan F, Hamlin DK, Shenoi J, Lin Y, Wilbur SM, Buchegger F, Pantelias A et al..  2010.  Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.. Bioconjugate chemistry. 21(7):1225-38. Abstract
P
Park SI, Shenoi J, Frayo SM, Hamlin DK, Lin Y, Wilbur SD, Stayton PS, Orgun N, Hylarides M, Buchegger F et al..  2011.  Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(23):7373-82. Abstract
B
Buchegger F, Press OW, Delaloye AB, Ketterer N.  2008.  Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.. The oncologist. 13(6):657-67. Abstract
Buchegger F, Press OW.  2011.  Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma.. EJNMMI research. 1(1):7. Abstract
Buchegger F, Antonescu C, Helg C, Kosinski M, Prior JO, Delaloye AB, Press OW, Ketterer N.  2011.  Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 52(6):896-900. Abstract